New 12-Month Prescription Policy: A Win-Win for Patients and the Health System
The New Zealand healthcare system is implementing a groundbreaking 12-month prescription policy, effective Sunday. This policy allows patients to receive a script for up to 12 months of medication, a significant increase from the previous three-month limit. With their doctor's approval, patients can now manage their long-term medications more effectively, reducing the frequency of visits to their healthcare provider.
However, this change has sparked concerns among pharmacists. Some have expressed worries that explaining the new system and adapting to the increased workload will be challenging, especially with a shortage of pharmacists in the country. Gemma Perry-Waterhouse, owner of Sanders Pharmacy in Te Awamutu, highlights the workforce issue, stating that the decline in the number of pharmacies in New Zealand exacerbates the problem.
Despite these challenges, Health Minister Simeon Brown sees the policy as a significant improvement. He argues that the previous system imposed unnecessary barriers for patients on stable, long-term medications, such as asthma inhalers, insulin for diabetes, and blood pressure tablets. This change not only reduces avoidable hospitalisations and improves health outcomes but also lowers long-term costs for both patients and the healthcare system.
The new policy is a step towards a more efficient and patient-centric healthcare system, but it also requires careful implementation to ensure a smooth transition for all involved parties.
